Reply to: Concerns on Potential Risk of Roxadustat in Promoting Tumor Progression: Double-Edged Sword of Hypoxia-Inducible Factor-1α Activation
J Clin Oncol
.
2025 Jan 13:JCO2402684.
doi: 10.1200/JCO-24-02684.
Online ahead of print.
Authors
Shun Lu
1
,
Jiong Wu
1
Affiliation
1
Shun Lu, MD, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; and Jiong Wu, MD, Cancer Hospital, Fudan University, Shanghai, China.
PMID:
39805067
DOI:
10.1200/JCO-24-02684
No abstract available